Accord Biopharma
Focus: Accord Biopharma is a publicly traded specialty pharmaceutical company based in Raleigh, NC, focused on biosimilars and generic/branded drugs across oncology, cardiovascular, and immunology indications.
Profile data last refreshed 12h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
4+3 this month
Stable — net +3 jobs in 30d
4 added, 1 removed. Backfill posture.
Should You Work at Accord Biopharma?
AI assessmentHigh-risk, revenue-dependent opportunity suitable only for commercial or operations professionals seeking stability; unsuitable for those prioritizing scientific innovation, career growth, or R&D involvement.
Why Work Here
- Established public company with stable revenue base anchored by lenalidomide ($262M Part D spending), providing financial predictability.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$262M Part DDeclining
Post-LOE
Core revenue driver (99% of company revenue) but facing post-LOE erosion; immunomodulatory mechanism targets hematopoietic tumors and MDS via cereblon pathway.
Help build intelligence for Accord Biopharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.